Endoscopic ultrasound after preoperative chemoradiation can help identify patients who benefit maximally after surgical esophageal resection

American Journal of Gastroenterology

Volumn 99, Issue 7, 2004, Pages 1258-1266

  Agarwal, Banke ^a,b   Swisher, Stephen ^a   Ajani, Jaffer ^a   Kelly, Kaitlyn ^a   Fanning, Christina ^a   Komaki, Ritsuko R ^a   Putnam Jr , Joe B ^a   Abu Hamda, Emad ^a   Molke, Kimber L ^a   Walsh, Garrett L ^a   Correa, Arlene M ^a   Ho, Linus ^a   Liao, Zhongxing ^a   Lynch, Patrick M ^a   Rice, David C ^a   Smythe, W Roy ^a   Stevens, Craig W ^a   Vaporciyan, Ara A ^a   Yao, James ^a   Roth, Jack A ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FLUOROURACIL; IRINOTECAN; PACLITAXEL;

ADULT; AGED; ARTICLE; ASPIRATION BIOPSY; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ENDOSCOPIC ECHOGRAPHY; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; ESOPHAGUS TUMOR; FEMALE; FOLLOW UP; HUMAN; LYMPH NODE METASTASIS; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; MALE; MINIMAL RESIDUAL DISEASE; MULTIMODALITY CANCER THERAPY; PATIENT SELECTION; POSTOPERATIVE COMPLICATION; PREOPERATIVE CARE; PRIORITY JOURNAL; RADIATION DOSE; STATISTICAL ANALYSIS; TREATMENT OUTCOME; TUMOR LOCALIZATION; ADENOCARCINOMA; ECHOGRAPHY; MIDDLE AGED; MORTALITY; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE;

ADENOCARCINOMA; ADULT; AGED; CARCINOMA, SQUAMOUS CELL; ENDOSONOGRAPHY; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; NEOPLASM, RESIDUAL; PREOPERATIVE CARE; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 3843137345     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2004.30692.x     Document Type: Article

References (26)

1. National Cancer Institute. National Cancer Institute Fact Book. Bethesda MD, U.S. Department of Health, Education and Welfare, Public health service, National Institute of Health, 1998.
2. Devesa SS, Blot WJ, Fraumeni JFJ. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 1998;83:2049-53.
3. Blot WJ, Devesa SS, Kneller RW, et al. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 1991;265:1287-89.
4. Ellis FH, Heatley GJ, Krasna MJ, et al. Esophagogastrectomy for carcinoma of the esophagus and cardia: A comparison of findings and results after standard resection in three consecutive eight year intervals with improved staging criteria. J Thorac Cardiovasc Surg 1997;113:836-48.
5. Law S, Fok M, Chow S, et al. Preoperative chemotherapy versus surgical therapy alone for squamous cell carcinoma of the esophagus: A prospective randomized trial. J Thorac Cardiovasc Surg 1997;114:210-17.
6. Bates BA, Detterbeck FC, Bernard SA, et al. Concurrent radiation therapy and chemotherapy followed by esophagectomy for localized esophageal carcinoma. J Clin Oncol 1996;14:156-163.
7. Jones DR, Detterbeck FC, Egan TM, et al. Induction chemotherapy followed by esophagectomy in patients with carcinoma of the esophagus. Ann Thorac Surg 1997;64:185-191.
8. Naunheim KS, Petruska PJ, Roy TS, et al. Multimodality therapy for adenocarcinoma of the esophagus. Ann Thorac Surg 1995;59:1085-91.
9. Bosset JF, Gignoux M, Triboulet JP, et al. Chemoradiotherapy followed by surgery compared with surgery alone in squamous cell carcinoma of esophagus. N Engl J Med 1997;337:161-7.
10. Walsh TN, Noonan N, Hollywood D, et al. A comparison of multi-modality therapy and surgery for esophageal adenocarcinoma. N Engl J Med 1996;335:462-7.
11. Nakadi IE, Houben JJ, Gay F, et al. Does esophagectomy cure a resectable esophageal cancer? World J Surg 1993;17:760-65.
12. Skinner DB. En bloc resection for neoplasms of the esophagus and cardia. J Thorac Cardiovasc Surg 1983;85:59-71.
13. Fok M, Sham JST, Choy D, et al. Post-operative radiotherapy for carcinoma of the esophagus: A prospective randomized controlled study. Surgery 1993;113:138-47.
14. Fujita H, Kakegawa T, Yamana H, et al. Mortality and morbidity rates, postoperative course, quality of life, and prognosis after extended radical lymphadenectomy for esophageal cancer. Ann Surg 1995;222:654-62.
15. Kok TC, Lanschot J, Siersema PD, et al. Neoadjuvant chemotherapy in operable esophageal squamous cell cancer: Final report of a phase III multicenter randomized controlled trial. Proc Am Soc Clin Oncol 1997;16:277.
16. Ruol A, Panel of Experts. Multimodality treatment for non-metastatic cancer of the thoracic esophagus. Results of a consensus conference held at the 6th World Congress of the International Society for Diseases of the Esophagus. Dis Esophagus 1996;9:39-55.
17. Ancona E, Ruol A, Santi S, et al. Only pathologic complete response to neoadjuvant chemotherapy improves significantly the long term survival of patients with resectable esophageal squamous cell carcinoma. Cancer 2001;91:2165-74.
18. Vogel SB, Mendenhall WM, Sombeck MD, et al. Down-staging of esophageal cancer after pre-operative radiation and chemotherapy. Ann Surg 1995;221:685-95.
19. Urba SG, Orringer MB, Turrisi A, et al. Randomized trial of preoperative chemoradiation versus surgery alone in patients with loco-regional esophageal carcinoma. J Clin Oncol 2001;19:305-13.
20. Catalano MF, Sivak MV Jr, Rice T, et al. Endosonographic features predictive of lymph node metastasis. Gastrointest Endosc 1994;40:442-46.
21. Bowrey DJ, Clark GWB, Roberts SA, et al. Serial endoscopic ultrasound in the assessment of response to chemotherapy for carcinoma of esophagus. J Gastrointest Surg 1999;3:462-67.
22. Beseth BD, Bedford R, Isacoff WH, et al. Endoscopic ultrasound does not accurately assess pathologic stage of esophageal cancer after neoadjuvant chemotherapy. Am Surg 2000;66:827-31.
23. Zuccaro G Jr, Rice TW, Goldblum J, et al. Endoscopic ultrasound cannot determine the suitability of esophagectomy after aggressive chemotherapy for esophageal cancer. Am J Gastroenterol 1999;94:906-12.
24. Pfau PR, Kochman ML. Pretreatment staging by endoscopic ultrasonography does not predict complete response to neoadjuvant chemoradiation in patients with esophageal carcinoma. Gastrointest Endosc 2000;52:583-6.
25. Weber WA, Ott K, Becker K, et al. Prediction of response to preoperative chemotherapy in adenocarcinomas of the esophagogastric junction by metabolic imaging. J Clin Oncol 2001;19:3058-65.
26. Suntharalingam M, Haas ML, Sonnett JR, et al. Accurate lymph node assessment prior to trimodality therapy for esophageal carcinoma. Cancer J 2001;7:509-15.